Company / Revenue
Rani Therapeutics Holdings, Inc. Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.0M
FY2025
5-year range
$0 / $2.7M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3M to $1M over the past 3 years.
Based on SEC 10-K filings.
$1M in FY2025 with a 3-year CAGR of -27.7%.
Declined from $3M to $1M over the past 3 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -27.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -27.7%, indicating a declining trend.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0M | - |
| FY2024 | $0 | -100.0% |
| FY2022 | $2.7M | +488.1% |
| FY2021 | $462.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026